Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma

Last updated:
2026-08-15
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 2/3 MULTICENTER TRIAL EVALUATING THE SAFETY AND EFFICACY OF ST-02 ON ABLATION OF UROTHELIAL CARCINOMAS IN THE UPPER URINARY TRACT

Intervention/treatment:
GEMCITABINE (ST-02)
Medical condition:
UROTHELIAL CANCER
Protocol code:
VPC-UC-201
Control number:
279774
Status:
Recruiting
Approved:
November 06, 2023
Trial phase:
Phase 2, Phase 3
For more information:
ClinicalTrials.gov - NCT06124976
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Dasa Durkotova
Role
CONTACT
Phone:
236 869 3437
Sponsor
DR. PETER BLACK

Locations

British Columbia

Vancouver Prostate Centre
Vancouver, British Columbia
Recruiting
Name
Genevive Moreau
Role
CONTACT
Phone:
604 875 4111
Extension 67898
Name
Marie-Pier St-Laurent, Dr.
Role
PRINCIPAL_INVESTIGATOR
Name
Peter Black, Dr.
Role
SUB_INVESTIGATOR
Name
Miles Mannas, Dr.
Role
SUB_INVESTIGATOR

Manitoba

Men's Health Clinic
Winnipeg, Manitoba, R3P 2S8
Recruiting
Name
Gayle Nickol
Role
CONTACT
Phone:
204 221 4476
Name
Jasmir Nayak, Dr.
Role
PRINCIPAL_INVESTIGATOR

Nova Scotia

Centre of Applied Urology Research, Nova Scotia Health Authority
Halifax, Nova Scotia
Recruiting
Name
Jessica Blandin
Role
CONTACT
Phone:
902 473 3470
Name
Ricardo Rendon, Dr.
Role
PRINCIPAL_INVESTIGATOR

Ontario

London Health Sciences Centre - Victoria Hospital
London, Ontario
Recruiting
Name
Kaydee Connors
Role
CONTACT
Phone:
519 685 8500
Extension 56366
Name
Melissa Huynh, Dr.
Role
PRINCIPAL_INVESTIGATOR
UHN - Princess Margaret Cancer Centre
Toronto, Ontario
Recruiting
Name
Amanda Liu
Role
CONTACT
Phone:
416 946 4501
Extension 3897
Name
Girish Kulkarni, Dr.
Role
PRINCIPAL_INVESTIGATOR

Quebec

Centre de recherche du CHUS
Sherbrooke, Quebec
Not yet recruiting
Name
Andrée-Anne Turcotte
Role
CONTACT
Phone:
819 346 1110
Extension 13446
Name
Claudio Jeldres, Dr.
Role
PRINCIPAL_INVESTIGATOR
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec
Not yet recruiting
Name
Amal Nadiri
Role
CONTACT
Phone:
514 890 8000
Extension 26074
Name
Mounsif Azizi, Dr.
Role
PRINCIPAL_INVESTIGATOR
McGill University Health Center
Montreal, Quebec
Recruiting
Name
Laetitia Burzoo
Role
CONTACT
Phone:
514 934 1934
Extension 36674
Name
Alexandra Buccilli
Role
CONTACT
Phone:
514 934 1934
Extension 34905
Name
Alexis Rompré-Brodeur, Dr.
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources